May 2026 performance summary: Delivered new peptides support for the repertoire diversity analysis tool, enabling calculation of diversity metrics for peptide libraries and expanding research capabilities. This was delivered via a merged change set tied to MILAB-6255 (PEPTIDES support) with commit 84a80051ccddcc13ed47cb100f9b02a7dcac011f. In parallel, stabilized the top-antibodies project by reverting SDK updates to restore compatibility and reliability, preventing downstream integration issues; commit 490b248fbd0e7a8d3dfbc34d69e649049b544790 (Revert

Month 2026-04 — Platforma Open: MixCR Clonotyping Overview: Delivered a key feature enhancement in the MiXCR Clonotyping block with improved data handling and an added preview run mode, accompanied by dependency/configuration updates to streamline maintenance and reduce runtime issues. What was delivered: - Key feature: MiXCR Clonotyping Block Enhancements and Preview Run Mode. Improved handling of sample label loading, introduced a new preview run mode, and updated dependencies/configurations to align with latest platform standards. - Implementation reference: Commit 00d9ecf871877cdada7616a7b09a0b225bb06288 (Merge PR #185 from platforma-open/julenmendieta/fix). Impact and outcomes: - Enables faster, safer iteration for clonotyping workflows through the new preview mode and improved data handling, reducing labeling errors and configuration drift. - Keeps dependencies up-to-date, simplifying future maintenance and deployments. Bugs fixed: - No major bugs reported or closed in this scope for this repository in April 2026. Technologies and skills demonstrated: - Code changes in the MiXCR clonotyping domain, dependency management, and configuration updates. - PR-driven collaboration and merge-based QA (PR #185 fix branch). - Traceability via commit-based history. Business value: - Improves reliability and speed of clonotyping tasks, lowers operational risk from mislabeling, and reduces maintenance overhead through updated dependencies and configurations.

September 2025: Delivered cross-platform SDK improvements and OS-specific enhancements across five core repos, enabling robust data processing pipelines and easier deployment. Key updates include macOS 13 NumPy support, OS compatibility enhancements for differential expression analysis, and full SDK updates across clonotype enrichment, STAR read mapping, and Top-Antibodies. These changes reduce install-time friction, improve performance, and lay groundwork for streamlined releases and downstream analytics.

February 2025 focused on clarifying the gene list comparison step in the differential-expression workflow. Delivered a UI improvement by updating the regDir label in main.tpl.tengo to explicitly indicate 'UP/Down-regulated gene list', reducing ambiguity and supporting more accurate interpretation of results. The change was implemented via commit a1f6181e5c7d6a4c87fb8622e681c62962421a79 with message 'Update regDir label to make it more intuitive'. No other major features or bug fixes were recorded this month for this repository. Overall impact: improved user understanding, smoother workflow, and better data interpretation in differential-expression analyses.